藥碼
LOP01
藥名
Loperamide 膠囊 2 mg
英文商品名
Loperamide 膠囊 2 mg
中文商品名
宜莫痢膠囊
螢幕名
Loperamide 膠囊 2 mg
劑型
Cap
規格
成分
藥理分類
Antidiarrhea Drugs
健保碼
AC197691G0
ATC碼
藥品圖片
外觀圖片
適應症
【缺藥訊息】
公告日期:2024/4/11。
缺藥品項:Loperamide 膠囊 2 mg。
缺藥原因:因製造問題缺藥。
替代藥品:同成分規格 IMO01 Imolex 膠囊 2 mg。
配套措施:藥品用罄關檔停用,建請改以同成分規格替代品項替代。

治療腹瀉
Diarrhea, acute; Diarrhea, chronic (Irritable bowel syndrome); High output ileostomy; Traveler's diarrhea
藥理
1. Prolong gastrointestinal transit time.
2.Reduces fecal volume, increases viscosity and bulk density, and decreases fluid and electrolyte volume depletion
藥動學
[Absorption]
Bioavailability: 0.3%

[Metabolism]
Metabolism: Oxidative N-demethylation, Major
Major Substrate of CYP2C8 and CYP3A4

[Excretion]
Renal: 2%
Feces: Extensive, 33% unchanged

[Elimination Half Life]
9 to 10.8 hours
禁忌症
1. abdominal pain in the absence of diarrhea
2. bacterial enterocolitis, caused by invasive organisms including Salmonella, Shigella, and Campylobacter, do not use as primary therapy
3. acute dysentery, do not use as primary therapy
4. hypersensitivity to loperamide or to any of the excipients;
5. infants below 24 months of age;
6. pseudomembranous colitis, associated with the use of broad spectrum antibiotics, do not use as primary therapy;
7. ulcerative colitis, acute, do not use as primary therapy
懷孕分類
C [FDA]
哺乳分類
Infant risk cannot be ruled out. [MDX]
副作用
[Central nervous system] Dizziness (1%)
[Gastrointestinal] Constipation (2% to 5%), abdominal cramps (<3%), nausea (<3%)
劑量和給藥方法
[Diarrhea, acute]
4 mg PO followed by 2 mg after each loose stool up to MAX 16 mg/day

[Diarrhea, chronic - Irritable bowel syndrome]
(initial) 4 mg PO followed by 2 mg after each loose stool up to MAX 16 mg/day
(maintenance) titrate to individual's need, average daily dosage 4-8 mg PO up to MAX 16 mg/day, may be taken as a single dose or in divided doses

[High output ileostomy]
dose used in some trials: 4 mg BID for 4 days, may then be increased to 12 mg daily for the remaining 3 days (total duration of therapy studied: 7 days)

[Traveler's diarrhea]
4 mg PO followed by 2 mg after each loose stool up to MAX 8 mg/day
小兒調整劑量
[Diarrhea, acute]
(first day dosage, 2 to 5 y/o, 13 to 20 kg) 1 mg PO TID;
(first day dosage, 6 to 8 y/o, 20 to 30 kg) 2 mg PO BID;
(first day dosage, 8 to 12y/o, greater than 30 kg) 2 mg PO TID;
(subsequent daily dosage, 2 to 12 y/o) 1 mg/10 kg of body weight PO only after a loose stool, total daily dose should not exceed dosages for the first day

[Diarrhea, chronic - Irritable bowel syndrome]
therapeutic dose in children has not been established; 0.08 to 0.24 milligram/kilogram/day in 2 to 3 divided doses have been used

[Traveler's diarrhea]
(2 to 5 y/o, 11 to 21.9 kg) 1 mg PO followed by 1 mg after each loose stool up to MAX 3 mg/day
(6 to 8 y/o, 22 to 26.9 kg) 2 mg PO followed by 1 mg after each loose stool up to MAX 4 mg/day
(9 to 11y/o, 27 to 43 kg) 2 mg PO followed by 1 mg after each loose stool up to MAX 6 mg/day
(12 y/o and older) 4 mg PO followed by 2 mg after each loose stool up to MAX 8 mg/day
腎功能調整劑量
No dosing adjustments are necessary.
肝功能調整劑量
安定性
藥袋資訊
臨床用途
腹瀉、下痢,本品替代原依莫瀉膠囊。
主要副作用
頭暈、嗜睡、口乾、腹脹、便秘、倦怠等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
藥局 H2 | 藥庫 口D21
藥品外觀
顏色
09
14
形狀
13
剝痕
標記1
標記2
其他
健保藥價
2
自費價
2.66
仿單
資料庫
健保給付規定